Essentra Regulatory News (ESNT)

16 December 2022

ESSENTRA PLCA leading global provider of essential components and solutions

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

The Board of Essentra plc ("Essentra" or "the Company") today announces the appointment of Kath Durrant as a Non-Executive Director with effect from 3 January 2023. Kath will also be a member of the Remuneration Committee.

Kath is a Non-Executive Director of Vesuvius plc, SIG plc and an advisor to Innovation RCA. She has previously served as a Non-Executive Director of Calisen plc and Renishaw plc.

Kath has extensive human resources experience gained from time working at GlaxoSmithKline plc and AstraZeneca plc. She also served as the Group Human Resources Director at Rolls Royce plc and Ferguson plc and until 2019 was Chief HR Officer at CRH plc.

Paul Lester, Chair, commented, "On behalf of the entire Board, I look forward to welcoming Kath to Essentra. Kath is our first Non-Executive Director appointment since Essentra announced its strategy as a pure-play components business. Kath's knowledge of people and cultures will bring great benefits to Essentra."

Kath Durrant has advised the Company that no other details are required to be disclosed under Listing Rule 9.6.13.

Enquiries

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 25 countries worldwide and includes over 3,000 employees, 12 manufacturing facilities, 23 distribution centres and 32 sales & service centres serving c.80,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com.